You are attending the #EAACI2023 meeting and are interested in #drugallergy? Let’s improve the diagnostic and management tools for our patients.
Please answer the survey below
https://t.co/nPxFMVsMSX
Interesting Oral Abstract Session on drug allergy and spot on comment by Annick Barbaud: allergologists on every continent should come together in deciding what is a low-risk patient when trying to delabel penicillin allergy @AnaCopaescu#PENFAST
📢 Two days until the EAACI Annual Congress is on! 🌟 To stay in the loop, make sure to follow EAACI on social media! 📲 Official congress hashtag is #EAACI2023. Let's create an engaging conversation together! 🌏 Register 👉 https://t.co/szNtc6E1BW #eaaci2023
#Immunotherapy with Pru p 3 for #food#allergy to peach and non-specific lipid transfer protein: a systematic review. Open Access. https://t.co/yLTW2VLbkP
#BSACI2023: we are proud to offer medical scholarships to attend our Annual Conference in Harrogate on 5-7 October 2023. Open to all FY2 doctors and IMT ST1-3 trainees in the UK with an interest in or considering a career in Allergy. Find out more at https://t.co/nCSmKFgOLf
"A very well-organised and informative meeting (...) developments in pathomechanisms and the treatment of #allergic diseases" - Prof. Thomas Luger, Speaker at The Allergic March #webinar.
Watch now On-Demand session and get your attendance #certificate at https://t.co/enJO6pPLZg
Intranasal epinephrine will soon be available for the treatment of anaphylaxis.
This research article compares pharmacokinetic and pharmacodynamic properties to intramuscular epinephrine. https://t.co/TWBT8mHgsV
Can people with #asthma SCUBA dive?
This informative article discusses the risks involved and precautions to consider for those who are interested.
https://t.co/9DocsTn69v